Cargando…
Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report
BACKGROUND: Antipsychotics are associated with abnormalities in glucose metabolism in patients with schizophrenia. Liraglutide, a GLP-1 receptor agonist, is Food and Drug Administration approved for the treatment of type 2 diabetes mellitus. However, ways to maintain the long-term stability of psych...
Autores principales: | Zhang, Lei, Yu, Wen-Juan, Zhu, Hui, Li, Hua-Fang, Qiao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353915/ https://www.ncbi.nlm.nih.gov/pubmed/36158023 http://dx.doi.org/10.12998/wjcc.v10.i21.7495 |
Ejemplares similares
-
Successful control of a case of severe insulin allergy with liraglutide
por: Kawanami, Daiji, et al.
Publicado: (2013) -
Liraglutide Suppresses Obesity and Hyperglycemia Associated with Increases in Hepatic Fibroblast Growth Factor 21 Production in KKA(y) Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2014) -
Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
por: Cheng, Kai-Chun, et al.
Publicado: (2020) -
Chorea Hyperglycemia Basal Ganglia Syndrome in a 63-Year-Old Male
por: Sperling, Michael, et al.
Publicado: (2018) -
Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro
por: Wang, Xing, et al.
Publicado: (2021)